The return on equity (ROE) for the stock stood at 16.84 per cent. Traded volume on the counter stood at 10:26AM shares and turnover at Rs 2.88 crore around that time. The stock of Aurobindo Pharma Ltd. quoted a 52-week high price of Rs 1023.1 and 52-week low prices of Rs 605.05, respectively.
The stock’s Beta value, which measures its volatility in relation to the broader market, stood at 1.06.
Promoters held 48.86 per cent stake in the company as of 31-Mar-2021, while foreign investors held 24.37 per cent and domestic institutional investors had 8.84 per cent.
The company reported consolidated sales of Rs 6498.31 crore for the quarter ended 31-Dec-2020, down 0.59 per cent from previous quarter’s Rs 6537.19 crore and down 9.66 per cent from the year-ago quarter’s Rs 5925.93 crore. Net profit after tax for the latest quarter stood at Rs 2946.46 crore, up 317.67 per cent from the same quarter a year ago.
The MACD signalled a bearish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices.
It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on topof the MACD to reflect “buy” or “sell” opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.